GoHealth (NASDAQ:GOCO - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research note issued on Saturday.
Separately, Royal Bank of Canada restated a "sector perform" rating and issued a $18.00 price target on shares of GoHealth in a research note on Monday, May 19th.
View Our Latest Stock Report on GoHealth
GoHealth Stock Performance
GOCO traded down $0.14 during midday trading on Friday, reaching $5.70. The company had a trading volume of 35,609 shares, compared to its average volume of 42,780. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. The business has a 50-day moving average of $8.11 and a two-hundred day moving average of $12.08. The company has a market cap of $135.31 million, a P/E ratio of -1.63 and a beta of 1.49. GoHealth has a 1 year low of $5.40 and a 1 year high of $21.00.
GoHealth (NASDAQ:GOCO - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.21). The company had revenue of $220.97 million during the quarter, compared to analysts' expectations of $225.91 million. GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. As a group, equities research analysts predict that GoHealth will post -5.5 earnings per share for the current fiscal year.
Institutional Investors Weigh In On GoHealth
A number of institutional investors have recently added to or reduced their stakes in GOCO. 4D Advisors LLC purchased a new stake in GoHealth during the 1st quarter valued at approximately $1,840,000. Point72 Asset Management L.P. purchased a new stake in GoHealth during the 4th quarter valued at approximately $675,000. Citadel Advisors LLC purchased a new stake in GoHealth during the 4th quarter valued at approximately $664,000. Ancora Advisors LLC purchased a new stake in GoHealth during the 4th quarter valued at approximately $408,000. Finally, Russell Investments Group Ltd. grew its holdings in GoHealth by 41,225.5% during the 4th quarter. Russell Investments Group Ltd. now owns 21,076 shares of the company's stock valued at $282,000 after buying an additional 21,025 shares in the last quarter. 24.21% of the stock is owned by hedge funds and other institutional investors.
GoHealth Company Profile
(
Get Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Further Reading
Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.